600713.SS
600713.SS
CNE000000KV1
NANJING PHARMACEUTICAL GP CO LT
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
6.72B EUR
6.54B EUR
6.91B EUR
7.15B EUR
Enterprise Value
19.57B EUR
13.36B EUR
14.41B EUR
9.93B EUR
Valuation Multiples
Trailing P/E
11.95x
12.64x
13.52x
13.9x
Forward P/E
--
--
--
--
Price to Sales
0.12x
0.16x
0.17x
0.17x
Price to Book
0.93x
0.9x
0.94x
0.99x
EV/Revenue
0.36x
0.32x
0.35x
0.24x
EV/EBITDA
13.3x
9.67x
10.22x
9.92x
Price to FCF (P/FCF)
--
--
--
8.69x
EV/FCF
--
--
--
12.08x
FCF Yield
-17.06%
-4.19%
-11.19%
11.51%
ende